More than $3 Billion Opportunity in Parenteral Nutrition Market in the Next 6 Years, Increasing Approval of Trace Elements Creating Competition Among the Players- Arizton

According to Arizton's latest research report, the global parenteral nutrition market will grow at a CAGR of 7% from 2021-2027. The rising concern about nutritional health due to the changing lifestyle of people, and the increasing need for nutritional support to achieve a healthy life, are the major drivers in the parenteral nutrition market. Moreover, the parenteral nutrition market observes huge innovations and advancements to sustain the competitive market. Market vendors are looking for more inorganic growth methods. In 2020, the leading market player Baxter International, well known for its clinical nutrition (including parenteral nutrition solutions), made a joint venture with VIPUN Medical, a pioneer in developing technology. This joint venture help in improving the medical nutrition segment. The company announced the agreement to commercialize the VIPUN gastric monitoring system, which is used for patients who are intolerant to enteral nutrition; Baxter's parenteral nutrition products help ensure the patient gets nutritional needs.
Advances in automated compounds in parenteral nutrition are gaining popularity in pediatric parenteral nutrition. Parenteral nutrition compounding in major hospitals and healthcare settings is now majorly automated using volumetric pump systems. In most US hospitals and healthcare settings, over 65% of hospitals use automated compounding devices. Parenteral nutrition solutions are complex to prepare and prescribe. Thus, several advances regarding automated systems were made in the parenteral nutrition industry.
Automixers is one of the most used automated compound elements in parenteral nutrition. Baxter, one of the leading companies in parenteral nutrition, offers automixers in the parenteral nutrition portfolio. Moreover, the company offers a new product ExactaMix Pro. As the modern pharmacy faces ever-evolving compounding needs, auto mixers give safety, accuracy, and flexibility with a new approach and smart features.

Click Here to Download the Free Sample Report: https://www.arizton.com/request-sample/3311

Trace elements (TE) used in parenteral nutrition products are becoming popular due to advances and increasing research and development activities. Previously, multi-trace elements were poorly appreciated and not subjected to thorough oversight by the US Food & Drug Administration (FDA). After ASPEN issued the dosage for parenteral nutrition, trace elements witnessed various developments. Various future-oriented research is taking place in the trace element segment. However, more clinical evidence is required to identify TE requirements of patients with unique needs. The increasing need will increase the future demand for trace element-based products.
The competitive rivalry in the parenteral nutrition market is tremendously increasing. A broad range of leading national and domestic players are in the market with high competition through product launches, partnerships, collaboration, and joint venture business strategies. Emerging market players are creating high competition with newer formulations and advances in the market. Emerging market players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging market players positively influences the competition in the parenteral nutrition market. The primary competition among market players is due to new product launches and emerging and gold-standard formulations. In parenteral nutrition, trace elements are emerging trends that will create high competition among players. In recent years, clinical nutrition and regulatory authorities announced guidelines for pediatric parenteral nutrition with trace elements, increasing the demand for trace elements-based products in preterm care. The growing research in parenteral nutrition formulations, new products launch, increasing global market expansion, and initiatives by market players will accelerate the significant competition.
North America is dominating the global parenteral nutrition market. The high healthcare expenditure and acceptance of home parenteral and other nutrition therapies across the US anticipate high market growth in the region. In addition, the region's growing geriatric population and high demand for healthcare services are driving up the hospitalization rate, which causes malnutrition, and the demand for parenteral nutrition among a high-targeted population of chronically ill and hospitalized patients. North America keeps making modest progress toward achieving the global nutrition target. The significant burden of malnutrition pushed the region to take a vital step toward the intake of nutrition, which improved the research and development and propelled the market growth in North America.

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3311

KEY COMPANY PROFILES
• Baxter
• B. Braun Melsungen
• Fresenius Kabi
• JW Pharmaceuticals
• Sichuan Kelun Pharmaceuticals
• Aculife
• Albert David
• Amanta Healthcare
• American Reagent
• BML PARENTERAL DRUGS
• Caritas Healthcare
• Eurofarma
• EuroLife Healthcare Pvt. Ltd.
• Farmoterapica
• Grifol
• ICU Medical
• Otsuka Pharmaceutical
• Soleo Health
• REVIV
• Pfizer
• Vifor Pharma

Know more about the market: https://www.arizton.com/market-reports/parenteral-nutrition-market

MARKET SEGMENTATION
Nutrients
• Macronutrients
• Automated Compounds
• Micronutrients
Indication
• Short-Term
• Long-Term
Patient Group
• Pediatric Patient Group
• Adult Patient Group
End-users
• Hospitals
• Ambulatory Care Settings
• Others
Geography
• APAC
o China
o India
o Japan
o South Korea
o Australia
• Europe
o Germany
o Italy
o Spain
o France
o The UK
• North America
o The US
o Canada
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o Turkey
o South Africa
o South Arabia

TABLE OF CONTENT
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY NUTRIENTS
4.3.2 MARKET BY INDICATION
4.3.3 MARKET BY PATIENT GROUP
4.3.4 MARKET BY END-USERS
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 ECONOMIC IMPACT OF MALNUTRITION & GROWTH OF PARENTERAL NUTRITION
8 PREMIUM INSIGHTS
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 ADVANCES IN TRACE ELEMENTS FOR PARENTERAL NUTRITION
9.2 AVAILABILITY OF STANDARDIZED AND COMMERCIAL PARENTERAL NUTRITION SOLUTIONS
9.3 GROWTH IN PREFERENCE FOR HOME PARENTERAL NUTRITION
10 MARKET GROWTH ENABLERS
10.1 INCREASING PREVALENCE OF CHRONIC DISORDERS
10.2 INCREASING PREVALENCE OF MALNUTRITION
10.3 INCREASING TARGET PATIENT POPULATION
11 MARKET RESTRAINTS
11.1 PARENTERAL NUTRITION CHALLENGES IN PRETERM INFANTS AND CHILDREN
11.2 AVAILABILITY OF ALTERNATIVE NUTRITION CARE METHODS
11.3 COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 NUTRIENTS INSIGHTS
12.1.2 PATIENT GROUP INSIGHTS
12.1.3 INDICATION INSIGHTS
12.1.4 END-USERS INSIGHTS
12.1.5 GEOGRAPHY INSIGHTS
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 NUTRIENTS
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 MACRONUTRIENTS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 AUTOMATED COMPOUNDS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 MICRONUTRIENTS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 INDICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 SHORT-TERM
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 LONG-TERM
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.1 PEDIATRIC
15.1.1 MARKET OVERVIEW
15.1.2 MARKET SIZE & FORECAST
15.1.3 MARKET BY GEOGRAPHY
15.2 ADULT
15.2.1 MARKET OVERVIEW
15.2.2 MARKET SIZE & FORECAST
15.2.3 MARKET BY GEOGRAPHY
16 END-USERS
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 AMBULATORY CARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 OTHERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 NUTRIENTS
18.3.1 MARKET SIZE & FORECAST
18.4 INDICATION
18.4.1 MARKET SIZE & FORECAST
18.5 PATIENT GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 END-USERS
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 NUTRIENTS
19.3.1 MARKET SIZE & FORECAST
19.4 INDICATION
19.4.1 MARKET SIZE & FORECAST
19.5 PATIENT GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 END-USERS
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 CHINA: MARKET SIZE & FORECAST
19.7.2 JAPAN: MARKET SIZE & FORECAST
19.7.3 INDIA: MARKET SIZE & FORECAST
19.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.7.5 AUSTRALIA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 NUTRIENTS
20.3.1 MARKET SIZE & FORECAST
20.4 INDICATION
20.4.1 MARKET SIZE & FORECAST
20.5 PATIENT GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 END-USERS
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 GERMANY: MARKET SIZE & FORECAST
20.7.2 FRANCE: MARKET SIZE & FORECAST
20.7.3 UK: MARKET SIZE & FORECAST
20.7.4 ITALY: MARKET SIZE & FORECAST
20.7.5 SPAIN: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 NUTRIENTS
21.3.1 MARKET SIZE & FORECAST
21.4 INDICATION
21.4.1 MARKET SIZE & FORECAST
21.5 PATIENT GROUP
21.5.1 MARKET SIZE & FORECAST
21.6 END-USERS
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 NUTRIENTS
22.3.1 MARKET SIZE & FORECAST
22.4 INDICATION
22.4.1 MARKET SIZE & FORECAST
22.5 PATIENT GROUP
22.5.1 MARKET SIZE & FORECAST
22.6 END-USERS
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST
22.7.3 SAUDI ARABIA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 BAXTER
23.2.2 B. BRAUN MELSUNGEN
23.2.3 FRESENIUS KABI
23.2.4 JW PHARMACEUTICAL
23.2.5 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
24 KEY COMPANY PROFILES
24.1 BAXTER
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 B. BRAUN MELSUNGEN
24.3 FRESENIUS KABI
24.4 JW PHARMACEUTICAL
24.5 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
25 OTHER PROMINENT VENDORS
25.1 ACULIFE
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ALBERT DAVID
25.3 AMANTA HEALTHCARE
25.4 AMERICAN REAGENT
25.5 BML PARENTERAL DRUGS
25.6 CARITAS HEALTHCARE
25.7 EUROFARMA
25.8 EUROLIFE HEALTHCARE
25.9 FARMOTERAPICA
25.10 GRIFOLS S.A.
25.11 ICU MEDICAL
25.12 OTSUKA PHARMACEUTICAL
25.13 SOLEO HEALTH
25.14 REVIV
25.15 PFIZER
25.16 VIFOR PHARMA
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY NUTRIENTS
27.3 MARKET BY INDICATION
27.4 MARKET BY PATIENT GROUP
27.5 MARKET BY END-USER
27.6 NUTRIENTS: MARKET BY GEOGRAPHY
27.6.1 MACRONUTRIENTS: MARKET BY GEOGRAPHY
27.6.2 AUTOMATED COMPOUNDS: MARKET BY GEOGRAPHY
27.6.3 MICRONUTRIENTS: MARKET BY GEOGRAPHY
27.7 INDICATION: MARKET BY GEOGRAPHY
27.7.1 SHORT-TERM: MARKET BY GEOGRAPHY
27.7.2 LONG-TERM: MARKET BY GEOGRAPHY
27.8 PATIENT GROUP: MARKET BY GEOGRAPHY
27.8.1 PEDIATRIC: MARKET BY GEOGRAPHY
27.8.2 ADULT: MARKET BY GEOGRAPHY
27.9 END-USERS: MARKET BY GEOGRAPHY
27.9.1 HOSPITALS: MARKET BY GEOGRAPHY
27.9.2 AMBULATORY CARE CENTERS: MARKET BY GEOGRAPHY
27.9.3 OTHERS: MARKET BY GEOGRAPHY
28 APPENDIX
28.1 ABBREVIATIONS

About Us:  
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Call: +1-312-235-2040 
          +1 302 469 0707 
Mail: enquiry@arizton.com

This release was published on openPR.